Erectile Dysfunction Devices Market Report 2024

This Erectile Dysfunction Devices market report covers industry characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The erectile dysfunction devices market size has grown rapidly in recent years. It will grow from $1.66 billion in 2023 to $1.87 billion in 2024 at a compound annual growth rate (CAGR) of 12.6%. The growth observed in the past can be linked to a greater awareness of erectile dysfunction, wider acceptance of treatment methods, an expanding aging population, an increase in chronic conditions, and advancements in device safety and efficacy.

The erectile dysfunction devices market size is expected to see rapid growth in the next few years. It will grow to $3.01 billion in 2028 at a compound annual growth rate (CAGR) of 12.7%. Future growth is expected due to the rising incidence of erectile dysfunction, a heightened focus on personalized treatments, the expansion of telemedicine and remote consultations, improved healthcare policies and insurance coverage, and a growing range of non-invasive treatment options. Key trends during this period include the development of smart devices with integrated monitoring capabilities, the adoption of minimally invasive treatments, home-based treatment solutions, advancements in biocompatible materials, and the use of artificial intelligence for tailored care.

The rising prevalence of prostate cancer is expected to drive the growth of the erectile dysfunction devices market. Prostate cancer, originating in the prostate gland - a small organ below the bladder responsible for producing part of semen - affects a significant number of men. The increase in prostate cancer cases is linked to aging populations, better detection methods, and lifestyle factors that may influence the disease's prevalence. Erectile dysfunction devices are crucial for prostate cancer patients, as they help restore sexual function and enhance quality of life after treatment, which can often affect erectile capabilities. For instance, Cancer Australia reported in January 2024 that approximately 24,217 new prostate cancer cases were projected for Australia in 2022. Men in 2022 had an estimated 1 in 6 (17%) chance of being diagnosed with prostate cancer by age 85. The age-standardized incidence rate was expected to be 151 cases per 100,000 males, with a 1 in 55 (1.8%) risk of death from prostate cancer by age 85. Hence, the increasing prevalence of prostate cancer is fueling the growth of the erectile dysfunction devices market.

Leading companies in the erectile dysfunction devices market are focusing on developing advanced, non-invasive products to gain a competitive edge. Non-invasive erectile dysfunction devices are medical tools designed to improve or restore erectile function without surgical intervention, often using methods such as vacuum therapy, electrical stimulation, or non-penetrative penile implants. For example, in June 2024, Ohh Med Medical, an Israel-based medical equipment manufacturer, introduced the VerticaPlus device for erectile dysfunction. This innovative device includes a cloud-based mobile app that enhances the therapy experience with real-time feedback and quality tracking. The upgraded version features the app as a personal coach, offering ongoing feedback, step-by-step tutorials, and customized settings for more effective therapy.

In September 2022, Advanced MedTech Holdings, a Singapore-based medical technology company, acquired WIKKON for an undisclosed amount. This acquisition strengthens AMTH's position in China and expands its global urology platform, combining WIKKON’s innovative technology with AMTH’s resources to better serve both domestic and international markets. WIKKON, based in China, specializes in solutions for treating erectile dysfunction.

Major companies operating in the erectile dysfunction devices market are Boston Scientific Corporation, Medline Industries LP, Coloplast Corporation, Hollister Incorporated, MTS Medical AG, Alma Lasers Ltd., Owen Mumford Ltd., Shenzhen Huikang Medical Apparatus Co. Ltd., Storz Medical AG, UroMatrix Medical Systems, Medispec Ltd., Zephyr Surgical Implants, Timm Medical Technologies Inc., Promedon GmbH, Zimmer MedizinSysteme GmbH, Mercury Healthcare Pvt. Ltd., Rigicon Inc., NOVAmedtek, Tyna International Ltd., Vacurect, The Elator, Pos-T-Vac Medical Inc., Silimed Indústria de Implantes.

North America was the largest region in the erectile dysfunction devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the erectile dysfunction devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the erectile dysfunction devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Erectile dysfunction devices are medical instruments intended to assist individuals with erectile dysfunction (ED) in achieving and sustaining an erection adequate for sexual activity. These devices utilize various methods, including suction, constriction, or medication delivery, to enhance blood flow to the penis or support its firmness.

There are two primary types of erectile dysfunction devices non-surgical and surgical. Non-surgical devices are designed to help men achieve and maintain an erection without the need for surgery. They are used to address conditions such as diabetes, neurological disorders, and hypertension, and can be either invasive or non-invasive. These devices cater to different age groups - under 40 years, 40-60 years, and over 60 years - and are utilized by various end-users including hospitals, clinics, ambulatory surgical centers, and others.

The erectile dysfunction devices market research report is one of a series of new reports that provides erectile dysfunction devices market statistics, including erectile dysfunction devices industry global market size, regional shares, competitors with a erectile dysfunction devices market share, detailed erectile dysfunction devices market segments, market trends and opportunities, and any further data you may need to thrive in the erectile dysfunction devices industry. This erectile dysfunction devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The erectile dysfunction devices market consists of sales of penile prostheses, injection therapy devices, urethral suppositories, and related products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.